In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-23 of 23 for your search:
Drug:  tiazofurin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: IUMC-851130, NCI-T85-0250R, T85-0250
2.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: IUMC-890117, NCI-T88-0075O, T88-0075
3.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: MDA-DM-88108, NCI-T88-0198C, T88-0198
4.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: BUMC-3333, NCI-T90-0213O, T90-0213
5.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor: NCI
Protocol IDs: MDA-DM-8420, NCI-T84-0369D, T84-0369
6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: MDA-DM-8516, NCI-T84-0421C, T84-0421
7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MAOP-8185
8.

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CAN-NCIC-IND11, NCI-T85-0019W, T85-0019, IND11
9.

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CAN-NCIC-IND9, NCI-T85-0018W, T85-0018, IND9
10.

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CAN-NCIC-IND10, NCI-T85-0101W, T85-0101, IND10
11.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CAN-NCIC-IND54, NCI-T90-0007O, T90-0007, IND54
12.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor: NCI
Protocol IDs: UARK-92016, NCI-T92-0173O, T92-0173
13.

Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: MSKCC-8367R, NCI-T83-1117W, T83-1117
14.

Phase: Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor:
Protocol IDs: NCI-83-C-31, NCI-MB-CPB-174, NCI-W83-0447, W83-0447
15.

Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: NCI-W82-1515, CTEPIS-0080, W82-1515
16.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 14 and over
Sponsor:
Protocol IDs: NCI-W83-0251
17.

Phase: Phase I
Type: Treatment
Status: Completed
Age: under 18
Sponsor:
Protocol IDs: NCI-83-C-38A, CCG-094, NCI-W83-0323, W83-0323
18.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI
Protocol IDs: NCI-W83-0339, CAN-NCIC-OTT-8207
19.

Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: MAYO-830102, NCI-T83-1072W
20.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor:
Protocol IDs: WCCC-CO-8295, NCI-W83-0581
21.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UTHSC-83405193, NCI-T84-0351W, T84-0351
22.

Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: CWRCC-ICC-1989, NCI-T88-0235D, T88-0235
23.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-9370
New Search